GOLDFINCH BIO, INC.

Profile

Company Names

GOLDFINCH BIO, INC.
GOLDFINCH BIOPHARMA, INC.

Addresses

215 FIRST STREET, CAMBRIDGE, MA 02142

Phone Numbers

617-585-2000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, OTHER HEALTH CARE

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$69,708,905.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-06-29 
$69,708,309.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2016-11-30 
$596.00 
$596.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LOUIS 
 
BRENNER 
DIRECTOR
ALLENA PHARMACEUTICALS, INC.   |  GOLDFINCH BIOPHARMA, INC.   |  GOLDFINCH BIO, INC.
ABBIE 
 
CELNIKER 
EXECUTIVE OFFICER, DIRECTOR
TALIGEN THERAPEUTICS INC   |  IMAGINAB, INC.   |  THIRD ROCK VENTURES IV, L.P.   |  GOLDFINCH BIOPHARMA, INC.   |  RHEOS MEDICINES, INC.   |  PANOPTICA, INC.   |  THIRD ROCK VENTURES V, L.P.   |  GOLDFINCH BIO, INC.   |  CEDILLA THERAPEUTICS, INC.   |  ABATA THERAPEUTICS, INC.   |  THIRD ROCK VENTURES VI, L.P.
WEN 
 
CHEN 
DIRECTOR
ULTIVUE, INC.   |  MESA BIOTECH, INC.   |  HISTOSONICS, INC.   |  GOLDFINCH BIO, INC.   |  BLUEJAY THERAPEUTICS, INC.   |  SIGMOID CAPITAL OFFSHORE FUND LTD
FRANK 
 
CZERWIEC 
EXECUTIVE OFFICER
GOLDFINCH BIO, INC.
CURTIS 
 
DEMICK 
EXECUTIVE OFFICER
GOLDFINCH BIO, INC.
NEIL 
 
EXTER 
EXECUTIVE OFFICER, DIRECTOR
SEVENTH SENSE BIOSYSTEMS, INC.   |  CORIDEA NC1, INC.   |  CYTOMX THERAPEUTICS, INC.   |  ELEMENT SCIENCE, INC.   |  RHYTHM METABOLIC, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  GOLDFINCH BIOPHARMA, INC.   |  PLIANT THERAPEUTICS, INC.   |  THIRD ROCK VENTURES V, L.P.   |  REVOLUTION MEDICINES, INC.   |  GOLDFINCH BIO, INC.   |  CEDILLA THERAPEUTICS, INC.   |  DECIBEL THERAPEUTICS, INC.   |  THIRD ROCK VENTURES VI, L.P.
JOY 
 
GHOSH 
DIRECTOR
GOLDFINCH BIO, INC.
JEAN-CHRISTOPHE 
 
HARMANGE 
EXECUTIVE OFFICER
GOLDFINCH BIO, INC.
ANTHONY 
 
JOHNSON 
EXECUTIVE OFFICER, DIRECTOR
CARDIOXYL PHARMACEUTICALS INC   |  INSURANCE HEDGE FUND, L.P.   |  EMPIRE GENOMICS, LLC   |  GIPHY, INC.   |  GOLDFINCH BIO, INC.   |  22ND CENTURY GROUP, INC.
KYLE 
 
KUVALANKA 
EXECUTIVE OFFICER
BLUEPRINT MEDICINES CORP   |  GOLDFINCH BIO, INC.   |  IMV INC.
FRANK 
 
MADDUX 
DIRECTOR
GOLDFINCH BIO, INC.
LORI 
 
RUDOLPH-OWEN 
EXECUTIVE OFFICER
GOLDFINCH BIO, INC.   |  CODAGENIX INC.
PETER 
 
THOMSON 
EXECUTIVE OFFICER
GOLDFINCH BIOPHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-07-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-29 
2017-01-23
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#